Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

NCT00765921 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Choroidal Melanoma

Interventions

DRUG: ranibizumab

Sponsor

Massachusetts Eye and Ear Infirmary

Collaborators

[object Object]